Pheochromocytoma and paraganglioma (PPGL) require prompt consideration and efficient
diagnosis and treatment to minimize associated morbidity and mortality. Once considered …

Context: Pheochromocytomas and paragangliomas (PHEO/PGL) are neuroendocrine
tumors that arise from sympathetic and parasympathetic paraganglia. Diagnosed rarely …

Objective: The aim was to formulate clinical practice guidelines for pheochromocytoma and
paraganglioma (PPGL). Participants: The Task Force included a chair selected by the …

Pheochromocytomas and paragangliomas (PPGLs) are rare neuroendocrine tumors that
arise from chromaffin cells of the adrenal medulla and the sympathetic/parasympathetic …

Neuroendocrine tumors (NETs) are rare, slow-growing neo-plasms characterized by their
ability to store and secrete different peptides and neuroamines. 1 Some of these substances …

This article aims to review current concepts in diagnosing and managing
pheochromocytoma and paraganglioma (PPGL). Personalized genetic testing is vital, as 40 …

Context: Mutations of the KCNJ5 gene have recently been identified in patients with
aldosterone-producing adenomas (APA). Objective: Our objective was to investigate the …

Hypertension may be the initial clinical presentation for at least 15 endocrine disorders. An
accurate diagnosis of endocrine hypertension provides clinicians with the opportunity to …

In this review, we focus on the use of biochemical markers for the diagnosis of
neuroendocrine tumors and exclusion of conditions that masquerade as neuroendocrine …

Malignant pheochromocytomas/paragangliomas are rare tumors with a poor prognosis.
Malignancy is diagnosed by the development of metastases as evidenced by recurrences in …